Medicofarma Biotech (WAR:MDB) Interest Expense : zł-0.03 Mil (TTM As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Medicofarma Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medicofarma Biotech's interest expense for the three months ended in Mar. 2024 was zł 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was zł-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medicofarma Biotech's Operating Income for the three months ended in Mar. 2024 was zł -0.03 Mil. Medicofarma Biotech's Interest Expense for the three months ended in Mar. 2024 was zł 0.00 Mil. Medicofarma Biotech has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Medicofarma Biotech Interest Expense Historical Data

The historical data trend for Medicofarma Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicofarma Biotech Interest Expense Chart

Medicofarma Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.01

-0.02

-0.01

Medicofarma Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-	-0.02	-0.01	-

Medicofarma Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł-0.03 Mil.

Medicofarma Biotech (WAR:MDB) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medicofarma Biotech's Interest Expense for the three months ended in Mar. 2024 was zł0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was zł-0.03 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was zł0.00 Mil.

Medicofarma Biotech's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Medicofarma Biotech had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Medicofarma Biotech (WAR:MDB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicofarma Biotech SA (WAR:MDB) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Soko?owska 9 lok. U19, Warsaw, POL, 01-142

Website

https://www.medicofarma.pl

Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.